Position in HLN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$303,022
+$48,877 QoQ
Shares Held
30,272
+20.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $7,470,447 across 34 Drug Manufacturers - Specialty & Generic names. HLN ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
27,846 | $3,291,675 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
88,173 | $1,221,196 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,056 | $626,186 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
24,651 | $456,536 | |
| 5 | VTRS |
Viatris Inc
|
26,426 | $357,015 | |
| 6 | HLN |
Haleon plc
This page
|
30,272 | $303,022 | |
| 7 | ESPR |
Esperion Therapeutics, Inc.
|
96,254 | $263,735 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
1,776 | $233,970 |
All Filings in HLN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $303,022 | 30,272 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $254,145 | 25,138 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $200,658 | 22,370 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $272,233 | 26,252 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $184,232 | 17,904 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $194,329 | 20,370 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $205,833 | 19,455 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $134,381 | 16,269 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $108,451 | 12,774 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $69,535 | 8,449 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $78,843 | 9,465 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $71,908 | 8,581 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $70,704 | 8,686 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $64,024 | 8,003 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $56,746 | 9,318 | Shares | Sole | 2022-11-10 | |
| No filing history on record for this holder in this stock. | ||||||